Literature DB >> 9236993

Asymptomatic carotid artery stenosis screening in patients with lower extremity atherosclerosis: a prospective study.

C de Virgilio1, K Toosie, T Arnell, R J Lewis, C E Donayre, J D Baker, M Melany, R A White.   

Abstract

Eighty-nine male veterans presenting to a vascular surgery clinic with symptomatic lower extremity atherosclerosis were prospectively screened by duplex scan for asymptomatic carotid artery stenosis (CAS). Their chief complaint was: claudication (90%), rest pain (6%), and ischemic ulcer or gangrene (4%). The mean ankle-brachial index (ABI) was 0.77. Twenty-five CAS > 50% were detected in 18 (20%) patients. Twelve CAS > 75% were detected in 11 (12%) patients. There was no difference between patients with and without CAS > 50% with regards to mean ABI, history of angina, diabetes, hypertension, prior coronary artery bypass, or history of smoking. Carotid bruit was associated with ipsilateral CAS > 50% [p < 0.0001, sensitivity (52%), specificity (88%), positive predictive value (41%), negative predictive value (92%)]. As a result of the screening, eight elective carotid endarterectomies have been performed to date in six (7%) patients with one transient twelfth cranial nerve paresis as the only postoperative complication. We conclude that: (1) male patients presenting with symptomatic lower extremity atherosclerosis have a 20% prevalence of asymptomatic CAS > 50%, (2) there is no correlation between the degree of lower extremity ischemia and CAS > 50%, (3) carotid bruit is significantly associated with CAS > 50%, but has a low sensitivity, and (4) routine CAS screening should be considered for all male patients with symptomatic lower extremity atherosclerosis regardless of whether a bruit is present.

Entities:  

Mesh:

Year:  1997        PMID: 9236993     DOI: 10.1007/s100169900063

Source DB:  PubMed          Journal:  Ann Vasc Surg        ISSN: 0890-5096            Impact factor:   1.466


  6 in total

Review 1.  [Cerebrovascular diseases].

Authors:  P J Kuhlencordt; J Röling; U Hoffmann
Journal:  Internist (Berl)       Date:  2009-08       Impact factor: 0.743

2.  Reliability of Two Ankle-Brachial Index Methods to Predict Silent Lacunar Infarcts: A Population-Based Study in Stroke-Free Older Adults (the Atahualpa Project).

Authors:  Oscar H Del Brutto; Robertino M Mera; David L Brown; Johnathan L Nieves; Mark J Sedler
Journal:  Int J Angiol       Date:  2016-06-08

3.  Prevalence of significant carotid artery stenosis in Iranian patients with peripheral arterial disease.

Authors:  Abolhassan Shakeri Bavil; Kamyar Ghabili; Seyed Ebrahim Daneshmand; Masoud Nemati; Moslem Shakeri Bavil; Hossein Namdar; Sheyda Shaafi
Journal:  Vasc Health Risk Manag       Date:  2011-10-11

4.  Comparison of carotid and lower limb atherosclerotic lesions in both previously known and newly diagnosed type 2 diabetes mellitus.

Authors:  Lian-Xi Li; Xing Wu; Jun-Xi Lu; Yin-Fang Tu; Li-Bo Yu; Mei-Fang Li; Wei-Xing Zhang; Jia-An Zhu; Guo-Yue Yuan; Yu-Qian Bao; Wei-Ping Jia
Journal:  J Diabetes Investig       Date:  2014-03-11       Impact factor: 4.232

5.  Effectiveness of an individualized home-based physical activity program in surgery-free non-endarterectomized asymptomatic stroke patients: a study protocol for the PACAPh interventional randomized trial.

Authors:  Mathilde Mura; Emeraude Rivoire; Leila Dehina-Khenniche; Michèle Weiss-Gayet; Bénédicte Chazaud; Camille Faes; Philippe Connes; Anne Long; Chantal L Rytz; Pauline Mury; Lidia Delrieu; Etienne Gouraud; Marine Bordet; Nellie Della Schiava; Patrick Lermusiaux; Matthieu Arsicot; Antoine Millon; Vincent Pialoux
Journal:  Trials       Date:  2022-02-14       Impact factor: 2.728

6.  Carotid stenosis: what is the high-risk population?

Authors:  Jong Hun Park; Alvaro Razuk; Paulo Fernandes Saad; Gustavo José Politzer Telles; Walter Khegan Karakhanian; Alexandre Fioranelli; Alessandra Caivano Rodrigues; Giuliano Giova Volpiani; Pollyanna Campos; Roberto Massayoshi Yamada; Valter Castelli; Roberto Augusto Caffaro
Journal:  Clinics (Sao Paulo)       Date:  2012-08       Impact factor: 2.365

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.